Matrix Metalloproteinase Inhibitors in Arthritis
- 1 January 1998
- journal article
- review article
- Published by Taylor & Francis in Journal of Enzyme Inhibition
- Vol. 13 (2) , 79-101
- https://doi.org/10.3109/14756369809035829
Abstract
(1998). Matrix Metalloproteinase Inhibitors in Arthritis. Journal of Enzyme Inhibition: Vol. 13, No. 2, pp. 79-101.Keywords
This publication has 65 references indexed in Scilit:
- Inhibition of Stromelysin-1 (MMP-3) by P1‘-Biphenylylethyl Carboxyalkyl DipeptidesJournal of Medicinal Chemistry, 1997
- Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancerEuropean Journal Of Cancer, 1996
- Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.Journal of Clinical Investigation, 1996
- Metalloprotease inhibitors halt collagen breakdown in IL-1 induced bovine nasal cartilage culturesInflammation Research, 1995
- Matrix Metalloproteinase Inhibitors Containing a [(Carboxyalkyl)amino]zinc Ligand: Modification of the P1 and P2' ResiduesJournal of Medicinal Chemistry, 1994
- Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc‐binding environments (HEXXHXXGXXH and Met‐turn) and topologies and should be grouped into a common family, the ‘metzincins’FEBS Letters, 1993
- Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritisArthritis & Rheumatism, 1993
- Detection of Stromelysin and Collagenase in Synovial Fluid From Patients with Rheumatoid Arthritis and Posttraumatic Knee InjuryArthritis & Rheumatism, 1992
- Inhibition of human collagenases by sulfur-based substrate analogsBiochemical and Biophysical Research Communications, 1991
- The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritisArthritis & Rheumatism, 1990